Rapamycin blocks tumor progression: unlinking immunosuppression from antitumor efficacy.

PubWeight™: 1.33‹?› | Rank: Top 10%

🔗 View Article (PMID 12042641)

Published in Transplantation on May 27, 2002

Authors

Fu L Luan1, Minoru Hojo, Mary Maluccio, Kouzaburo Yamaji, Manikkam Suthanthiran

Author Affiliations

1: Department of Transplantation Medicine, New York-Presbyterian Hospital, New York, NY 10021, USA.

Articles citing this

Role of mTOR signaling in tumor cell motility, invasion and metastasis. Curr Protein Pept Sci (2011) 1.37

Engineering the ABA plant stress pathway for regulation of induced proximity. Sci Signal (2011) 1.35

Pemphigus autoimmunity: hypotheses and realities. Autoimmunity (2011) 1.23

RAD001 (everolimus) inhibits tumour growth in xenograft models of human hepatocellular carcinoma. J Cell Mol Med (2008) 1.19

mTOR signaling in cancer cell motility and tumor metastasis. Crit Rev Eukaryot Gene Expr (2010) 1.13

Immunosuppressive cyclosporin A activates AKT in keratinocytes through PTEN suppression: implications in skin carcinogenesis. J Biol Chem (2010) 1.10

Prolyl isomerase Pin1 is highly expressed in Her2-positive breast cancer and regulates erbB2 protein stability. Mol Cancer (2008) 1.09

Pyrimethamine inhibits adult polycystic kidney disease by modulating STAT signaling pathways. Hum Mol Genet (2011) 1.09

A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma. BMC Cancer (2010) 1.06

Recent developments in the treatment of renal cell carcinoma. Ther Adv Urol (2013) 1.05

Treating rheumatic patients with a malignancy. Arthritis Res Ther (2011) 1.03

Management and prevention of post-transplant malignancies in kidney transplant recipients. Clin Kidney J (2015) 0.97

Overview of immunosuppression in liver transplantation. World J Gastroenterol (2009) 0.96

Sirolimus inhibits the growth and metastatic progression of hepatocellular carcinoma. J Cancer Res Clin Oncol (2008) 0.95

Effect of sirolimus on urinary bladder cancer T24 cell line. J Exp Clin Cancer Res (2009) 0.92

Vascular profile characterization of liver tumors by magnetic resonance imaging using hemodynamic response imaging in mice. Neoplasia (2011) 0.91

The Role of mTOR Inhibitors in Liver Transplantation: Reviewing the Evidence. J Transplant (2014) 0.86

Evolution and management of de novo neoplasm post-liver transplantation: a 20-year experience from a single European centre. Hepatol Int (2010) 0.86

Inhibition of mTOR in kidney cancer. Curr Oncol (2009) 0.86

Post-transplantation malignancy: a cell autonomous mechanism with implications for therapy. Trans Am Clin Climatol Assoc (2009) 0.83

Long-term efficacy and safety of a calcineurin inhibitor-free regimen in live-donor renal transplant recipients. J Am Soc Nephrol (2008) 0.82

Management of recurrent hepatocellular carcinoma after liver transplant. World J Hepatol (2015) 0.81

Intrahepatic cholangiocarcinoma in a transplant liver--selective internal radiation therapy followed by right hemihepatectomy: report of a case. World J Surg Oncol (2014) 0.81

Elevated cutaneous Smad activation associates with enhanced skin tumor susceptibility in organ transplant recipients. Clin Cancer Res (2009) 0.81

Antineoplastic effects of mammalian target of rapamycine inhibitors. World J Transplant (2012) 0.80

P70S6K and Elf4E dual inhibition is essential to control bladder tumor growth and progression in orthotopic mouse non-muscle invasive bladder tumor model. J Korean Med Sci (2015) 0.79

Cancer immunotherapy via combining oncolytic virotherapy with chemotherapy: recent advances. Oncolytic Virother (2016) 0.79

Rapamycin enhances adenovirus-mediated cancer imaging and therapy in pre-immunized murine hosts. PLoS One (2013) 0.77

Neoplastic disease after liver transplantation: Focus on de novo neoplasms. World J Gastroenterol (2015) 0.77

Sirolimus therapy following early cyclosporine withdrawal in transplant patients: mechanisms of action and clinical results. Int J Nanomedicine (2006) 0.75

Transplantation: can sirolimus prevent skin cancer in transplant recipients? Nat Rev Nephrol (2010) 0.75

Transgenic expression of the N525S-tuberin variant in Tsc2 mutant (Eker) rats causes dominant embryonic lethality. Sci Rep (2014) 0.75

Everolimus and Malignancy after Solid Organ Transplantation: A Clinical Update. J Transplant (2016) 0.75

A Surgical Perspective on Targeted Therapy of Hepatocellular Carcinoma. Diseases (2015) 0.75

Articles by these authors

HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med (2008) 7.42

Rapamycin inhibits the growth and metastatic progression of non-small cell lung cancer. Clin Cancer Res (2004) 5.40

Messenger RNA for FOXP3 in the urine of renal-allograft recipients. N Engl J Med (2005) 5.02

Identification of a B cell signature associated with renal transplant tolerance in humans. J Clin Invest (2010) 3.59

Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations. Transplantation (2005) 3.57

Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice. J Exp Med (2007) 2.86

Noninvasive diagnosis of BK virus nephritis by measurement of messenger RNA for BK virus VP1 in urine. Transplantation (2002) 2.86

MicroRNA expression profiles predictive of human renal allograft status. Proc Natl Acad Sci U S A (2009) 2.36

Dendritic cells with TGF-beta1 differentiate naive CD4+CD25- T cells into islet-protective Foxp3+ regulatory T cells. Proc Natl Acad Sci U S A (2007) 2.10

Rapamycin is an effective inhibitor of human renal cancer metastasis. Kidney Int (2003) 1.83

Stereotactic body radiotherapy for primary hepatocellular carcinoma. Int J Radiat Oncol Biol Phys (2011) 1.80

Gut microbial community structure and complications after kidney transplantation: a pilot study. Transplantation (2014) 1.60

Phase I feasibility trial of stereotactic body radiation therapy for primary hepatocellular carcinoma. Clin Transl Oncol (2010) 1.55

Noninvasive prediction of organ graft rejection and outcome using gene expression patterns. Transplantation (2008) 1.50

Noninvasive detection of renal allograft inflammation by measurements of mRNA for IP-10 and CXCR3 in urine. Kidney Int (2004) 1.48

Tacrolimus enhances transforming growth factor-beta1 expression and promotes tumor progression. Transplantation (2003) 1.16

MicroRNAs: small RNAs with big effects. Transplantation (2010) 1.15

CD27(+) (memory) B cell decrease and apoptosis-resistant CD27(-) (naive) B cell increase in aged humans: implications for age-related peripheral B cell developmental disturbances. Int Immunol (2005) 1.15

Angiogenic factors in superimposed preeclampsia: a longitudinal study of women with chronic hypertension during pregnancy. Hypertension (2012) 1.14

Systemic transforming growth factor-beta1 gene therapy induces Foxp3+ regulatory cells, restores self-tolerance, and facilitates regeneration of beta cell function in overtly diabetic nonobese diabetic mice. Transplantation (2005) 1.13

Hypertension, kidney disease, HIV and antiretroviral therapy among Tanzanian adults: a cross-sectional study. BMC Med (2014) 1.10

Hyperexpression of Foxp3 and IDO during acute rejection of islet allografts. Transplantation (2007) 1.08

CD103 mRNA levels in urinary cells predict acute rejection of renal allografts. Transplantation (2003) 1.07

Enhanced granulysin mRNA expression in urinary sediment in early and delayed acute renal allograft rejection. Transplantation (2004) 1.07

Mitochondrial targeting with antioxidant peptide SS-31 prevents mitochondrial depolarization, reduces islet cell apoptosis, increases islet cell yield, and improves posttransplantation function. J Am Soc Nephrol (2006) 1.05

Transforming growth factor beta and progression of renal disease. Kidney Int Suppl (2003) 1.04

MicroRNA sequence profiles of human kidney allografts with or without tubulointerstitial fibrosis. Transplantation (2012) 1.03

Transforming growth factor beta signaling, vascular remodeling, and hypertension. N Engl J Med (2006) 1.01

Validation of noninvasive diagnosis of BK virus nephropathy and identification of prognostic biomarkers. Transplantation (2010) 0.99

Noninvasive diagnosis of acute rejection of renal allografts. Curr Opin Organ Transplant (2010) 0.98

Discovery and validation of a molecular signature for the noninvasive diagnosis of human renal allograft fibrosis. Transplantation (2012) 0.98

Increased frequency of CD27- (naive) B cells and their phenotypic alteration in HIV type 1-infected patients. AIDS Res Hum Retroviruses (2004) 0.97

Serine proteinase inhibitor-9, an endogenous blocker of granzyme B/perforin lytic pathway, is hyperexpressed during acute rejection of renal allografts. Transplantation (2003) 0.96

Epidemiology of BK virus in renal allograft recipients: independent risk factors for BK virus replication. Transplantation (2008) 0.95

Targeted metabolic profiling of hepatocellular carcinoma and hepatitis C using LC-MS/MS. Electrophoresis (2013) 0.94

Measurement of apoptosis of intact human islets by confocal optical sectioning and stereologic analysis of YO-PRO-1-stained islets. Transplantation (2005) 0.94

Genomic biomarkers correlate with HLA-identical renal transplant tolerance. J Am Soc Nephrol (2013) 0.94

A comparison of the antitumor effects of interferon-alpha and beta on human hepatocellular carcinoma cell lines. Cytokine (2006) 0.93

Urinary cell levels of mRNA for OX40, OX40L, PD-1, PD-L1, or PD-L2 and acute rejection of human renal allografts. Transplantation (2010) 0.90

Proapoptotic Bax is hyperexpressed in isolated human islets compared with antiapoptotic Bcl-2. Transplantation (2002) 0.90

Enforced c-REL deficiency prolongs survival of islet allografts1. Transplantation (2002) 0.89

Independent risk factors for urinary tract infection and for subsequent bacteremia or acute cellular rejection: a single-center report of 1166 kidney allograft recipients. Transplantation (2013) 0.88

Urinary cell mRNA profiles predictive of human kidney allograft status. Immunol Rev (2014) 0.88

Correlation between interleukin-15 and granzyme B expression and acute lung allograft rejection. Transpl Immunol (2004) 0.87

Circulating levels of 25-hydroxyvitamin D and acute cellular rejection in kidney allograft recipients. Transplantation (2014) 0.87

On the detection of anti-HLA antibodies using single antigen bead Luminex assay: lot-to-lot variations in MFI. Transplantation (2013) 0.85

Early corticosteroid withdrawal in recipients of renal allografts: a single-center report of ethnically diverse recipients and recipients of marginal deceased-donor kidneys. Transplantation (2012) 0.85

Molecular signatures of urinary cells distinguish acute rejection of renal allografts from urinary tract infection. Transplantation (2003) 0.85

Transcriptional profiling to assess the clinical status of kidney transplants. Nat Clin Pract Nephrol (2006) 0.85

Persistence of pandemic influenza H1N1 virus in young patients after oseltamivir therapy in the 2009-2010 season: a comparison with seasonal H1N1 with or without H275Y mutation. J Infect Chemother (2011) 0.84

Post-transplantation malignancy: a cell autonomous mechanism with implications for therapy. Trans Am Clin Climatol Assoc (2009) 0.83

Immunosuppressive drug therapy. Cold Spring Harb Perspect Med (2013) 0.83

[Evaluation of an immunochromatography test kit for rapid diagnosis of influenza]. Kansenshogaku Zasshi (2003) 0.83

Possible involvement of prolonging spinal µ-opioid receptor desensitization in the development of antihyperalgesic tolerance to µ-opioids under a neuropathic pain-like state. Addict Biol (2011) 0.83

Desensitization of GABA(B) receptor signaling by formation of protein complexes of GABA(B2) subunit with GRK4 or GRK5. J Cell Physiol (2007) 0.83

Transforming growth factor beta and excess burden of renal disease. Trans Am Clin Climatol Assoc (2009) 0.82

Diannexin decreases inflammatory cell infiltration into the islet graft, reduces β-cell apoptosis, and improves early graft function. Transplantation (2010) 0.82

Dendritic cells with TGF-β1 and IL-2 differentiate naive CD4+ T cells into alloantigen-specific and allograft protective Foxp3+ regulatory T cells. Transplantation (2012) 0.81

Noninvasive diagnosis of acute rejection of solid organ transplants. Front Biosci (2004) 0.81

Pharmacokinetics of oxycodone after intravenous and subcutaneous administration in Japanese patients with cancer pain. J Pain Palliat Care Pharmacother (2014) 0.81

Noninvasive prognostication of polyomavirus BK virus-associated nephropathy. Transplantation (2013) 0.80

Downregulation of CXCR5 in CD27- B cells of HIV-1 infected patients. J Med Virol (2004) 0.80

Lysophosphatidic acid aberrancies and hepatocellular carcinoma: studies in the MDR2 gene knockout mouse. Cancer Invest (2013) 0.79

Bile acids conjugation in human bile is not random: new insights from (1)H-NMR spectroscopy at 800 MHz. Lipids (2009) 0.79

The natural history, risk factors and outcomes of polyomavirus BK-associated nephropathy after renal transplantation. Nat Clin Pract Nephrol (2006) 0.78

GABA(B) receptors do not internalize after baclofen treatment, possibly due to a lack of β-arrestin association: study with a real-time visualizing assay. Synapse (2012) 0.78

Concurrent acute cellular rejection is an independent risk factor for renal allograft failure in patients with C4d-positive antibody-mediated rejection. Transplantation (2012) 0.78

HLA identical non-chimeric and HLA disparate chimeric renal transplant tolerance. Clin Transpl (2013) 0.78

Possible involvement of β-endorphin in a loss of the coordinated balance of μ-opioid receptors trafficking processes by fentanyl. Synapse (2011) 0.77

[Varicella-zoster virus symptoms and polyneuropathy in a patient with human immunodeficiency virus infection not improved until highly active anti-retroviral therapy added to acyclovir therapy]. Kansenshogaku Zasshi (2006) 0.77

Kinetic analysis of Mycobacterium tuberculosis-specific cytokine production by PBMC in adults after BCG vaccination. J Infect Chemother (2005) 0.77

Measuring exposed magnetic fields of welders in working time. Ind Health (2011) 0.77

Characteristics of Circulating Donor Human Leukocyte Antigen-specific Immunoglobulin G Antibodies Predictive of Acute Antibody-mediated Rejection and Kidney Allograft Failure. Transplantation (2015) 0.77

S(+)-ketamine suppresses desensitization of γ-aminobutyric acid type B receptor-mediated signaling by inhibition of the interaction of γ-aminobutyric acid type B receptors with G protein-coupled receptor kinase 4 or 5. Anesthesiology (2011) 0.77

HIV-infected kidney graft recipients managed with an early corticosteroid withdrawal protocol: clinical outcomes and messenger RNA profiles. Transplantation (2013) 0.76

Adhesiolysis and targeted steroid/local anesthetic injection during epiduroscopy alleviates pain and reduces sensory nerve dysfunction in patients with chronic sciatica. J Anesth (2008) 0.76

Visualization of bile homeostasis using (1)H-NMR spectroscopy as a route for assessing liver cancer. Lipids (2008) 0.76

Urinary-cell mRNA and acute kidney-transplant rejection. N Engl J Med (2013) 0.75

Transplantation: Pump it up: conserving a precious resource? Nat Rev Nephrol (2009) 0.75

Should hepatitis C virus infection be a contraindication to renal transplantation? Nat Clin Pract Nephrol (2008) 0.75

Excretion of anti-angiogenic proteins in patients with chronic allograft dysfunction. Nephrol Dial Transplant (2012) 0.75

Noninvasive diagnosis of BK virus nephritis by measurement of messenger RNA for BK VP1 virus in urine. Transplantation (2003) 0.75

Maturation of monocyte-derived dendritic cells by Hochu-ekki-to, a traditional Japanese herbal medicine. Int Immunopharmacol (2004) 0.75

Transplantation: Personalizing induction therapy in kidney transplantation. Nat Rev Nephrol (2009) 0.75

The relationship between the daily dosage of the carbapenem meropenem (MEPM) and MEPM-resistant Pseudomonas aeruginosa. J Infect Chemother (2008) 0.75

Mean arterial blood pressure while awaiting kidney transplantation is associated with the risk of primary nonfunction. Transplantation (2012) 0.75

Two V(H)5 family genes expressed by human peripheral B cells display differential mutational frequencies in the V(H) region. Mol Immunol (2002) 0.75

Transplantation: a report of progress. Transplantation (2013) 0.75

The Nobel Prize-winning work of Ralph Steinman (1943-2011) and its relevance to transplantation. Transplantation (2013) 0.75

Optimal modes and targets of gene therapy in transplantation. Immunol Rev (2003) 0.75

Transplantation: a report of progress. Transplantation (2008) 0.75

[Willingness to implement mental health measures among small-scale enterprise employers in Ohta ward, Tokyo, Japan]. Sangyo Eiseigaku Zasshi (2002) 0.75

Transplantation: a report of progress. Transplantation (2010) 0.75